Registry of Lobbyists

Registration - Consultant

UCB Pharma Canada / CHUCK RACHLIS, Consultant

Registration Information

Client name: UCB Pharma Canada
Lobbyist name: CHUCK RACHLIS, Consultant
Initial registration start date: 2007-03-13
Registration status: Inactive
Registration Number: 778451-15038

Version 2 of 3 (2007-08-28 to 2008-02-19)

Version 2 of 3 (2007-08-28 to 2008-02-19) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.

A. Registrant

Consultant lobbyist name: CHUCK RACHLIS    Lobbyist business address
Consulting firm: S. A. Murray Consulting Inc.
1220 YONGE STREET, SUITE 203
TORONTO, ON  M4T 1W1
Canada
Position: VICE PRESIDENT
Telephone number: 416-922-5152  
Fax number: 416-922-9870  
 
Former public office holder: Yes
Payment is contingent on the success of the undertaking: No

B. Information about Client

Client: UCB Pharma Canada
4145 North Service Road, Suite 200
Burlington, ON  L7L 6A3
Canada
Telephone number: 905-315-5065
Fax number: 905-336-0040  
 
Client Representative: Robert Hamilton
 
The client is a subsidiary of the following parent companies: UCB S.A.
Allee de la Recherche 60
B-1070
Brussels
Belgium

Coalition: The client is not a coalition.
Subsidiary: The client does not have any subsidiaries that could be affected by the outcome of the undertaking.
Individual, organization or corporation: The client's activities are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
 
Was the client funded in whole or in part by any domestic or foreign government institution in the last completed financial year? No
 

C. Lobbying Activity Information

Federal departments or organizations which have been or will be communicated with during the course of the undertaking: Finance Canada (FIN), Health Canada (HC), Industry Canada, Members of the House of Commons
Communication techniques that have been used or are expected to be used in the course of the undertaking:
Informal communications, Meetings, Presentations, Telephone calls, Written communications, whether in hard copy or electronic format
 
Subject Matter: Areas of Concern: Health, Industry, Intellectual Property, Science and Technology
 

Details Regarding the Identified Subject Matter

Categories Description
Regulation regulation of pharmaceutical and biologic products




Date Modified: